40
Hypercell Technologies raises $2.96M in biotech funding round in Ithaca
Company raise · Raising · ITHACA, NY · Form D filed 2026-10-14
Hypercell Technologies Inc., a Delaware biotech corporation based in Ithaca, NY, is raising up to $4.42M under Regulation D exemption 06b. The company has sold $2.96M to 14 investors so far with $1.47M remaining in the offering.
other
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Bruno Georges Jactel | Executive Officer, Director |
| Loic DeBlais | Executive Officer |
| Samuel Jactel | Executive Officer, Director |
| James Cali | Director |
| Tony Puri | Director |
Signed by Bruno Jactel, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.